Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls-Reference-Cited by-同舟云学术

Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls

Published:1991-06 Issue:2 Volume:85 Page:335-348
ISSN:0014-4819
Container-title:Experimental Brain Research
language:en
Short-container-title:Exp Brain Res

Author:

Taylor J. R.,Elsworth J. D.,Roth R. H.,Sladek J. R.,Collier T. J.,Redmond D. E.

Publisher

Springer Science and Business Media LLC

Subject

General Neuroscience

Link

http://link.springer.com/content/pdf/10.1007/BF00229411.pdf

Reference56 articles.

1. Altman J (1974) Observational study of behavior: sampling methods. Behavior 49: 222–267

2. Bankiewicz KS, Oldfield EH, Chiueh CC, Doppman JL, Jacobowitz DM, Kopin IJ (1986) Hemiparkinsonism in monkeys after unilateral internal carotid artery infusions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci 39: 7–16

3. Baulu J, Redmond DE Jr (1978) Some sampling considerations in the quantitation of monkey behavior under field and captive conditions. Primates 19: 391–399

4. Benecke R, Rothwell JC, Dick JPR, Day BL, Marsden CD (1987) Disturbance of sequential movements in patients with Parkinson's disease. Brain 110: 361–379

5. Björklund A, Stenevi U (1979) Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 177: 555–560

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining the unknowns for cell therapies in Parkinson's disease;Disease Models & Mechanisms;2022-09-27

2. D1, not D2, dopamine receptor activation dramatically improves MPTP-induced parkinsonism unresponsive to levodopa;European Journal of Pharmacology;2021-02

3. Generation of Pluripotent Stem Cells Using Somatic Cell Nuclear Transfer and Induced Pluripotent Somatic Cells from African Green Monkeys;Stem Cells and Development;2020-10-01

4. On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson’s and Huntington’s Disease;Frontiers in Aging Neuroscience;2020-09-03

5. Cell therapy for Parkinson's disease: Why it doesn't work every time;Movement Disorders;2019-06-24